共 14 条
[1]
[2]
[3]
[4]
Role of advanced glycation end products in cardiovascular disease[J] Zeinab Hegab;Stephen Gibbons;Ludwig Neyses;Mamas A Mamas; World Journal of Cardiology 2012,
[5]
[6]
Liraglutide inhibits autophagy and apoptosis induced by high glucosethrough GLP-1R in renal tubular epithelial cells[J] X. Zhao;G. Liu;H. Shen;B. Gao;X. Li;J. Fu;J. Zhou;Q. Ji International Journal of Molecular Medicine 2015,
[7]
Molecular Basis of Cardioprotective Effect of Antioxidant Vitamins in Myocardial Infarction[J] Ramón Rodrigo;Matías Libuy;Felipe Feliú;Daniel Hasson;Claiton Leonetti Lencina <journal-title>BioMed Research International 2013,
[8]
Advanced Glycation End Products and Diabetic Cardiovascular Disease[J] Anand Prasad;Peter Bekker;Sotirios Tsimikas Cardiology in Review 2012,
[9]
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications[J] RavichandranRamasamy;Shi FangYan;Ann MarieSchmidt Annals of the New York Academy of Sciences 2011,
[10]
Sitagliptin Augments Protective Effects of GLP-1 against Advanced Glycation End Product Receptor Axis in Endothelial Cells[J] Y. Ishibashi;T. Matsui;M. Takeuchi;S. Yamagishi Horm Metab Res 2011,

